About
Hula Therapeutics is a clinical-stage immunotherapy company that identifies tumor-specific targets presented by the Human Leukocyte Antigen system and engineers therapies to selectively kill tumor cells while minimizing toxicity to healthy tissues, focusing on solid tumors.
Explore Hula Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.